Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trialThe Lancet (British edition), 2023-03, Vol.401 (10378), p.733-746 [Peer Reviewed Journal]2023 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00221-0Full text available |
|
2 |
Material Type: Article
|
Sotorasib versus docetaxel for previously treated non-small- cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trialLANCET, 2023-03, Vol.401 (10378), p.733-746 [Peer Reviewed Journal]ISSN: 0140-6736 ;EISSN: 1474-547XFull text available |
|
3 |
Material Type: Article
|
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS G12C mutation: a randomised, open-label, phase 3 trialThe Lancet (British edition), 2023-03, Vol.401 (10378), p.733 [Peer Reviewed Journal]Copyright © 2023 Elsevier Ltd. All rights reserved. ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00221-0 ;PMID: 36764316Full text available |